貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析

貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析

ID:27033605

大?。?05.00 KB

頁(yè)數(shù):74頁(yè)

時(shí)間:2018-11-30

貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析_第1頁(yè)
貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析_第2頁(yè)
貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析_第3頁(yè)
貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析_第4頁(yè)
貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析_第5頁(yè)
資源描述:

《貝伐單抗脂質(zhì)體聯(lián)合離子電滲對(duì)兔眼后段給藥的分析》由會(huì)員上傳分享,免費(fèi)在線(xiàn)閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫(kù)。

1、-------廣州醫(yī)科大學(xué)碩士學(xué)位論文freebevacizumabconcentrations,ELISAkitwasused.Thedatawereanalyzedbyt-testandanalysisofvariance.Results:1.Theresultsofocularexamination:Alltheexperimentalanimalswerehealthyduringthewholeproceduals.Therearenoobviouscomplicationsintheeyes,su

2、chaseyeinfections,cornealopacity,cataract,retinalhemorrhageeta1.2.Thecomparisonofdrugconcentration:GroupA、BandC,theaqueoushumorconcentrationofbevaeizumabwas(11.08±0.46)μg/mland(27.53±0.37)μg/mland(38.48±0.15)μg/mlintherighteyes,after24h,respectively.Avitreo

3、usconcentrationofbevaeizumabwas(7.29±0.17)μg/mland(19.25±0.15)μg/mland(31.87±0.25)μg/mlintherighteyes,respectively.Iontophoresisgroup,bevacizumabconcentrationintherighteyesofaqueoushumorandvitreouscavitycomparison.Thedrugconcentrationofaqueoushumorwerehighe

4、rthaninthevitreouscavity,thedifferencewasstatisticallysignificant(P<0.01).Betweeniontophoresisgroup,therewerestatisticallysignificantofdrugconcentrationsinthesameareasthroughvarianceanalysisandcomparisonbetweengroups.Bevacizumabsolutioneyedropsgroup(lefteye

5、ingroupA),theaqueoushumorandvitreouscavitywerenotdetectedindrugconcentration.Bevacizumabliposomessolutioneyedropsgroup(lefteyeingroupB),drugconcentrationintheaqueoushumorwas(1.30±0.11)μg/mlandthevitreouscavitywasnotdetectedindrugconcentration.Becausethetwog

6、roupsfailedtodetectdrugconcentrationorconcentrationistoolow,arenotincludedforcomparison.Bevacizumabconcentration(receivedintravitrealinjectedbybevacizumab)inaqueoushumorandvitreouscavitywas(19.37±0.21)μ-----------4萬(wàn)方數(shù)據(jù)-----------英文摘要g/mland(179.83±0.11)μg/m

7、linthelefteyes.Comparedwiththedrugconcentrationindifferentcurrentintensityofiontophoresis,thedifferencehadstatisticalsignificance,P<0.01.Conclusion:Bevacizumabliposomescombinediontophoresisadministration,nosignificantsideeffects,isasafemodeofadministration.

8、Currentinarangeof0.5~2.5mA,thegreaterthecurrentintensity,bevacizumabliposomesintheeyeoftheimportquantityislarger.Bevacizumabliposomescombinediontophoresiswiththerapeuticsignificance,fordrugconcentratio

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫(huà)的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無(wú)此問(wèn)題,請(qǐng)放心下載。
2. 本文檔由用戶(hù)上傳,版權(quán)歸屬用戶(hù),天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶(hù)請(qǐng)聯(lián)系客服處理。